Published Date: 08 Mar 2023
Medicare covers people with disabilities who are young enough to get pregnant. Contraception is often not covered for these patients and they opt for hysterectomy or tubal ligation, which may be covered.
Read Full NewsImmune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.
As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.
Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.
1.
Spouses of Cancer Patients May Be at Increased Risk of Suicide
2.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
3.
Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.
4.
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer
5.
Alternative breast imaging techniques beyond mammography.
1.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
2.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
3.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
4.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
5.
The Importance of Early Detection in Skin Cancer: Why Regular Skin Exams Matter
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
Navigating the Complexities of Ph Negative ALL - Part XIV
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation